Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMTROUI)

Drug Name
Zavegepant Drug Info
Synonyms Vazegepant; UNII-ODU3ZAZ94J; ODU3ZAZ94J; BHV-3500; BDBM50436107
Indication
Disease Entry ICD 11 Status REF
Migraine 8A80 Approved [1]
Coronavirus Disease 2019 (COVID-19) 1D6Y Phase 2 [2]
Therapeutic Class
Antiviral Agents
Cross-matching ID
PubChem CID
53472683
CAS Number
CAS 1337918-83-8
TTD Drug ID
DMTROUI

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Calcitonin gene-related peptide receptor (CGRPR) TTY6O0Q CALRL_HUMAN Inhibitor [2]
HUMAN calcitonin gene-related peptide type 1 receptor (CALCRL) TT67OLB CALRL_HUMAN Inhibitor [2]

References

1 FDA Approved Drug Products from FDA Official Website. 2023. Application Number: 216386.
2 Safety and Efficacy Trial of Zavegepant* Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen